fbpx

Year

2019
Monday 18 November at 11:00 ET /16:00 GMT / 17:00 CET Sanifit will host a webcast on Monday November 18 at 11am ET / 5pm CET / 4pm GMT on the results of the international Phase 2b CaLIPSO study of lead candidate SNF472 in patients with end stage kidney disease (ESKD) on hemodialysis. Joan Perelló, CEO and Alexander M....
Lund, Sweden, 7 November 2019 08.00 am CET, – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, today publishes the interim report for the third quarter 2019. BONESUPPORT’S BEST QUARTER EVER “Sales in the quarter are our highest ever, with strong growth in both Europe and the US....
From today, ten promising research talents can call themselves Lundbeck Foundation Fellows. They each receive DKK 10 million to conduct their research over the next five years, making this the largest Lundbeck Foundation Fellows programme ever. This is the thirteenth time the Lundbeck Foundation is awarding fellowships and, yet again, the recipients are young researchers,...
A major scientific study funded by the Lundbeck Foundation will analyse the genetics underlying febrile seizures – and seek to answer a question that has long challenged scientists: Do febrile seizures increase the risk of developing epilepsy later in life? Any parent’s alarm bells will begin to ring when their babies or toddlers have febrile...
Lund, Sweden, 12:00 pm CET, 31 October 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids. During October, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 8,125 due to the exercise of warrants. As of 31 October 2019, the number of...
Cambridge, UK and Indianapolis, US – 30 October 2019: Acacia Pharma Group plc (the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission of the 940,442 Ordinary Shares of...
Palma, Spain and San Diego, USA, 30 October 2019 – Sanifit, a clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced that the international Phase 2b CaLIPSO study of SNF472 in patients with end stage kidney disease (ESKD) on hemodialysis has met its primary endpoint. The study demonstrated a reduction in coronary...
Lund, Sweden, 08.00 am CET, 30 October 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, will publish its Q3 2019 interim report on the 7 November 2019 at 08.00 am CET. The Company will hold a conference call and an online presentation on the same day...
How do you design drugs with fewer side effects? And how can you stimulate the brain using a weak electric current or ultrasound? These are a few of the topics covered by a number of scientific research projects that the Lundbeck Foundation has recently decided to support with grants totalling DKK 100 million. There are...
Cytologist and Professor with Special Responsibilities at the University of Copenhagen Simon Bekker-Jensen is awarded the Lundbeck Foundation Young Investigator Prize. He was appointed professor at the young age of 36, has published his results in the world’s leading scientific journals and has dedicated his career to discovering how cells respond to stress and how,...
1 2 3 4 13

News

Experienced neuroscientist at the helm of The Brain Prize
30. June 2020
Eight promising young researchers receive Lundbeck Foundation Fellowships
16. June 2020
Denmark Gets Its First Master’s Degree Programme in Neuroscience
4. June 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge